Free Trial
NASDAQ:ATHE

Alterity Therapeutics (ATHE) Stock Price, News & Analysis

Alterity Therapeutics logo
$4.11 +0.24 (+6.20%)
Closing price 07/8/2025 03:59 PM Eastern
Extended Trading
$4.06 -0.06 (-1.34%)
As of 06:29 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Alterity Therapeutics Stock (NASDAQ:ATHE)

Key Stats

Today's Range
$3.86
$4.20
50-Day Range
$3.41
$4.84
52-Week Range
$1.00
$5.87
Volume
20,740 shs
Average Volume
144,161 shs
Market Capitalization
$36.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00
Consensus Rating
Moderate Buy

Company Overview

Alterity Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

ATHE MarketRank™: 

Alterity Therapeutics scored higher than 53% of companies evaluated by MarketBeat, and ranked 499th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Alterity Therapeutics has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Alterity Therapeutics has received no research coverage in the past 90 days.

  • Read more about Alterity Therapeutics' stock forecast and price target.
  • Percentage of Shares Shorted

    0.81% of the float of Alterity Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Alterity Therapeutics has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Alterity Therapeutics has recently decreased by 8.61%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Alterity Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Alterity Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.81% of the float of Alterity Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Alterity Therapeutics has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Alterity Therapeutics has recently decreased by 8.61%, indicating that investor sentiment is improving significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, Alterity Therapeutics insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      38.80% of the stock of Alterity Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      Only 2.14% of the stock of Alterity Therapeutics is held by institutions.

    • Read more about Alterity Therapeutics' insider trading history.
    Receive ATHE Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

    ATHE Stock News Headlines

    Alterity Therapeutics highlighted at MSA Congress
    Here's the last trade you should make before heading out for the weekend tomorrow.
    Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.
    See More Headlines

    ATHE Stock Analysis - Frequently Asked Questions

    Alterity Therapeutics' stock was trading at $3.31 on January 1st, 2025. Since then, ATHE shares have increased by 24.2% and is now trading at $4.11.

    Alterity Therapeutics shares reverse split on Monday, January 9th 2023.The 1-10 reverse split was announced on Monday, January 9th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 9th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

    Shares of ATHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Alterity Therapeutics investors own include NVIDIA (NVDA), GE Aerospace (GE), Broadcom (AVGO), Meta Platforms (META), Dorian LPG (LPG), CymaBay Therapeutics (CBAY) and

    Company Calendar

    Today
    7/09/2025
    Next Earnings (Estimated)
    8/04/2025
    Fiscal Year End
    6/30/2026

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED - BIOMED/GENE
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:ATHE
    CIK
    1131343
    Employees
    10
    Year Founded
    N/A

    Price Target and Rating

    High Price Target
    $12.00
    Low Price Target
    $12.00
    Potential Upside/Downside
    +192.0%
    Consensus Rating
    Moderate Buy
    Rating Score (0-4)
    2.50
    Research Coverage
    2 Analysts

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Pretax Margin
    N/A

    Debt

    Sales & Book Value

    Annual Sales
    N/A
    Price / Cash Flow
    N/A
    Book Value
    $1.04 per share
    Price / Book
    3.95

    Miscellaneous

    Free Float
    5,427,000
    Market Cap
    $36.46 million
    Optionable
    Not Optionable
    Beta
    0.71
    A Beginner's Guide to Investing in Cannabis Cover

    Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

    Get This Free Report

    This page (NASDAQ:ATHE) was last updated on 7/9/2025 by MarketBeat.com Staff
    From Our Partners